For Home Collection or Appointments at the Lab: +91-20-6901-5000

Reproductive and Women's Health

Test No. Test Name Analytical Technique Sample required TAT
RPDMLP304 MLPA for Aneuploidies (all chromosomes) in Products of Conception (POC) MLPA Products of Conception in Saline 10 days
RPDSEQ391 Y-Chromosome Microdeletions AFLP/ Fragment Analysis Blood in EDTA 5 days
HAESEQ031 Full HBB gene sequencing for beta Thalassemia NGS Blood in EDTA 4-5 weeks
HAESEQ034 Full HBB gene sequencing for beta Thalassemia + HPLC NGS + HPLC Blood in EDTA 3-4 weeks
HAESEQ031 Targeted (known) mutation detection in HBB gene with Maternal Cell Contamination (MCC) for Prenatal samples CE-Seq/ ARMS PCR + Fragment analysis Antenatal sample (CVS, Amniotic Fluid) 10 days
HAEPCR396 Detection of IVS1-5 G>C mutation in HBB gene ARMS real time PCR Blood in EDTA, Antenatal sample 2-3 days
HAESEQ397 Targeted (known) sequencing in HBB gene for Beta Thalassemia CE-Seq Blood in EDTA 2 weeks
ONCNGS045 BRCause NGS Panel - Full sequencing of BRCA1 and BRCA2 NGS Blood in EDTA 4-5 weeks
ONCNGS046 BRCause Extended NGS Panel - Full sequencing of BRCA1, BRCA2, ATM, BRIP1, NBN, RAD51C, RAD51D, PALB2, STK11, CHEK2, PTEN, TP53, CDH1, MLH1, MSH2, MSH6, PMS2, APC, SMAD4, BLM, FANCC, ERCC2 and EPCAM genes NGS Blood in EDTA 4-5 weeks
ONCMLP203 BRCopy: BRCA1, BRCA2 copy number variations and large gene rearrangements by MLPA MLPA Blood in EDTA 10 days
HAEQPC133 Factor V Leiden (FVL R506Q/ G1691A) mutation analysis ARMS real time PCR Blood in EDTA 3 days
HAESEQ134 Factor II / Prothrombin (FII G20210A) mutation analysis CE-Seq Blood in EDTA 7 days
RPDFRG072 Maternal Cell Contamination (MCC) Fragment Analysis Antenatal sample and Parental sample in EDTA 5 days
INDHC2440 Human Papillomavirus (HPV) testing for Cervical Cancer Risk by HC2 Hybrid Capture 2 Cervical specimen in SurePath collection vial Every Thursday
INDNGS441 Human Papillomavirus (HPV) genotyping by NGS (RUO) NGS Cervical specimen in SurePath collection vial 4-5 weeks